1. Home
  2. LFUS vs BIO Comparison

LFUS vs BIO Comparison

Compare LFUS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Littelfuse Inc.

LFUS

Littelfuse Inc.

SELL

Current Price

$413.82

Market Cap

10.4B

Sector

Energy

ML Signal

SELL

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

SELL

Current Price

$363.46

Market Cap

10.1B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
LFUS
BIO
Founded
1927
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
10.1B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
LFUS
BIO
Price
$413.82
$363.46
Analyst Decision
Buy
Hold
Analyst Count
4
3
Target Price
★ $496.25
$328.33
AVG Volume (30 Days)
172.2K
★ 249.4K
Earning Date
10-28-2026
10-29-2026
Dividend Yield
★ 0.77%
N/A
EPS Growth
N/A
★ 142.61
EPS
★ 2.96
N/A
Revenue
$757,853,000.00
★ $2,583,200,000.00
Revenue This Year
$23.70
N/A
Revenue Next Year
$10.07
$2.13
P/E Ratio
$139.80
★ N/A
Revenue Growth
N/A
★ 0.65
52 Week Low
$233.36
$236.73
52 Week High
$500.57
$396.23

Technical Indicators

Market Signals
Indicator
LFUS
BIO
Relative Strength Index (RSI) 42.68 45.57
Support Level $389.23 $358.85
Resistance Level $428.88 $391.87
Average True Range (ATR) 11.72 12.72
MACD -2.09 -2.02
Stochastic Oscillator 13.18 29.96

Price Performance

Historical Comparison
LFUS
BIO

About LFUS Littelfuse Inc.

Littelfuse is a supplier of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. Littelfuse also holds a minority power semiconductor business, primarily serving high-voltage industrial applications. Littelfuse sells globally across both distribution and direct channels, and organizes its business into the three segments of electronics, transportation, and industrial. Littelfuse is a serial acquirer of smaller, bolt-on adjacent firms.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: